ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Aging"

  • Abstract Number: 1072 • ACR Convergence 2025

    Inclusion of Older Adults in Pharmacologic Randomized Controlled Clinical Trials of Autoimmune Rheumatic Diseases: A Systematic Review

    Manuel Carpio Tumba1, Raisa Lomanto Silva2, Lily Sung3, Laura C. Pedraza-Arévalo4, Sneha Gupta5, Jeenah Gwak6, Aida Mohamadi7, Diana Louden8, Rachael Stovall8, Namrata Singh9, Didem Saygin10, Sarah Lieber11, Jiha Lee12 and Sebastian E Sattui13, 1University of Pittsburgh, Pittsburgh, PA, 2Massachusetts General Hospital, Boston, MA, 3Stanford University Hospital & Clinics, Hayward, CA, 4St. Barnabas Hospital, New York, NY, 5University of Pittsburgh Medical Center McKeesport, McKeesport, PA, 6Stanford University, Palo Alto, CA, 7Tehran University of Medical Sciences, Tehran, Iran, 8University of Washington, Seattle, WA, 9University of Washington, Bellevue, WA, 10Rush University Medical Center, Chicago, IL, 11Hospital for Special Surgery, New York, NY, 12University of Michigan, Ann Arbor, MI, 13Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: A growing number of older adults are living with autoimmune rheumatic diseases (AIRDs) as the global population is aging. And yet, they remain underrepresented…
  • Abstract Number: 0167 • ACR Convergence 2025

    Geographic and Demographic Patterns of Rheumatoid Arthritis in the United States: Insights from GBD 2021

    Punith Chirumamilla1, Sameer Kumar Majety2, Rithish Nimmagadda3, Ravi Medarametla4, Priya Sunkara5, Pranathi Bandarupalli6, Anjani Mahesh Kumar Cherukuri7 and Himaja Anne8, 1Baptist Memorial Hospital North Mississippi, Oxford, MS, 2School of Medicine, Xiamen University, China, Kakinada, Andhra Pradesh, India, 3One Brooklyn Health, New York, NY, 4Mamata Medical College, Guntur, Andhra Pradesh, India, 5White River Health, Batesville, AZ, 6Mercy St Vincent Medical Center, Toledo, OH, 7Guntur Medical College, Guntur, Andhra Pradesh, India, 8Hind Institute of Medical Sciences, Sitapur, Uttar Pradesh, India

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune, systemic disease with a rising U.S. healthcare burden. Utilizing Global Burden of Disease (GBD) 2021 estimates, we analyzed…
  • Abstract Number: 2002 • ACR Convergence 2025

    Methods to Address Survival Bias and Competing Risks in Estimating the Causal Risks of Gout on Dementia Risk

    Joshua Baker1, Harlan Sayles2, Chung-Chou Chang3, Brian Coburn4, Bryant England2 and Ted Mikuls2, 1University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3University of Pittsburgh, Pittsburgh, PA, 4Hospital of the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Informative censoring in epidemiologic research studies (the loss of data from the risk set that is related to the exposure and/or outcome) can cause…
  • Abstract Number: 1065 • ACR Convergence 2025

    Age of Disease Onset and Risk of Serious Infection with anti-TNF Use in Older Adults with Rheumatoid Arthritis

    Jiha Lee1, Sofia Pedro2 and Kaleb Michaud3, 1University of Michigan, Ann Arbor, MI, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Older age is a recognized risk factor for serious infection (SI) associated with anti-TNF therapy in rheumatoid arthritis (RA). Among older adults with RA,…
  • Abstract Number: 1921 • ACR Convergence 2025

    Re-escalation of Treatment in Older Adults with Rheumatoid Arthritis After Anti-TNF Therapy De-escalation

    Jiha Lee1, Jonathan Martindale2, Una Makris3 and Julie Bynum2, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Ann Arbor, 3UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Older adults with rheumatoid arthritis (RA) treated with biologic disease-modifying antirheumatic drugs (bDMARDs), including anti-TNFs, are at an increased risk of adverse effects. Current…
  • Abstract Number: 0972 • ACR Convergence 2025

    Prominent endothelial senescence in systemic sclerosis skin

    Poulami Dey1, William D Brodie2, Megan N Mattichak3, Alexander Cai3, Qi Wu4, Johann Gudjonsson5, Dinesh Khanna5, John Varga5 and Pei-Suen Tsou5, 1Michigan Medicine, Ann Arbor, MI, 2Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, Ann Arbor, 3Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, 4Michigan Medicine, Ann Arbor, 5University of Michigan, Ann Arbor, MI

    Background/Purpose: Systemic sclerosis (SSc) is characterized by extensive damage of the microvessels in multiple organs. We and others showed that endothelial cells (ECs) isolated from…
  • Abstract Number: 1886 • ACR Convergence 2025

    Thirty Percent of Older Adults with Rheumatic Disease Receive High-Risk Medication

    Christine Anastasiou1, Eric Roberts2, gabriela Schmajuk3 and Jinoos Yazdany4, 1Stanford University, Pleasanton, CA, 2University of California, San Francisco, SF, CA, 3University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA, 4UCSF, San Francisco, CA

    Background/Purpose: High-risk medications (HRMs) may increase the risk of adverse events such as falls and fractures, hospitalizations, hospital length of stay, and death in older…
  • Abstract Number: 0950 • ACR Convergence 2025

    Ep300-Catalyzed Rad50 Lactylation Compromises Genomic Stability and Drives CD4+T cells Cell Senescence in SLE

    mingyang zhang1, huanzi dai2, cun lan3 and mingyang sun3, 1Daping Hospital, Army Medical University, chongqing, Chongqing, China (People's Republic), 2Daping Hospital & Research Institute of Surgery, Army Medical University, Chongqing, PR China., Chongqing, China (People's Republic), 3Daping Hospital, Army Medical University, chongqing, China (People's Republic)

    Background/Purpose: Senescent CD4+ T cells are increasingly implicated in systemic lupus erythematosus (SLE) pathogenesis. While metabolic reprogramming in lupus T cells enhances glycolysis and lactate…
  • Abstract Number: 1805 • ACR Convergence 2025

    Human meniscus histopathological and transcriptomic changes at early and advanced stages of knee osteoarthritis

    Takuya Sakamoto1, Merissa Olmer1, chelsea Kenvisay1, Rachel Miller2, Anne-Marie Malfait3, Darryl D'Lima4, William Bugbee5, Hannah Swahn6 and Martin Lotz7, 1Scripps Research Institute, La Jolla, CA, 2Rush University Medical Center, Chicago, IL, 3Rush University, Oak Park, IL, 4Scripps Clinic, San Diego, CA, 5Scripps Clinic, La Jolla, CA, 6Scripps Research Institute, Carlsbad, CA, 7Scripps Research, La Jolla, CA

    Background/Purpose: The knee menisci are essential in joint biomechanics while meniscus damage is a driver of knee osteoarthritis (OA) and an important source of knee…
  • Abstract Number: 0893 • ACR Convergence 2025

    Transcriptomic insights into GCA compared to clinically diverse controls: Inflammation, Aging, Therapeutic Targets and the role of SPP1 in the temporal artery

    Ingrid Lindquist1, Alisha Eskew2, Dongsoek Choi3, David Wilson4, Diva Salomao5, Hillary Stiefel4, Daniel Albert4, Kiana Vakil-Gilani6, Daniela Ghetie7, James Rosenbaum8 and Marcia Friedman9, 1Portland VA Medical Center, Portland, OR, 2OHSU, Portland, OR, 3OHSU, Portland, 4Casey Eye Institute OHSU, Portland, OR, 5Mayo Clinic, Rochester, MN, 6PeaceHealth, Portland, OR, 7OHSU, Lake Oswego, OR, 8Legacy Devers Eye Institute, Portland, OR, 9Immpact Bio, Beaverton, OR

    Background/Purpose: Giant cell arteritis (GCA) is the most common vasculitis in people over 50 years old and is a clinical diagnosis bolstered by non-specific inflammatory…
  • Abstract Number: 0166 • ACR Convergence 2024

    Limitations in Activities of Daily Living Among Individuals with SLE

    Laura Plantinga1, Jinoos Yazdany2, Courtney Hoge3, Charmayne M. Dunlop-Thomas4 and Patti Katz5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 5UCSF, San Rafael, CA

    Background/Purpose: A better understanding of the capacity of individuals with SLE to perform routine daily life tasks is needed to effectively support the independence and…
  • Abstract Number: 2146 • ACR Convergence 2024

    Validation of the Simple Calculated Osteoporosis Risk Estimation and Osteoporosis Self-assessment Tool Among People Aging with HIV in Peru

    Joselito Malca-Hernandez1, Daniel Granda2, Ahmed Abdeen3, Yvett Pinedo4, Flor Gonzales5, Miguel Tapia6, Patricia Garcia7 and Evelyn Hsieh8, 1Yale School of Public Health, Department of Epidemiology of Microbial Diseases / School of Public Health- Universidad Peruana Cayetano Heredia, Epidemiology, STD, and HIV Unit, New Haven, CT, 2Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado, Lima, Lima, Peru, 3Yale School of Medicine, Section of Rheumatology, Allergy and Immunology / Penn State College of Medicine, State College, New Haven, CT, 4Hospital Nacional Arzobispo Loayza, Department of Infectious Diseases, Lima, Peru, 5Ministry of Health of Peru, Department of Infectious Diseases, Lima, Peru, 6Ministry of Health, Department of Infectious Diseases, Lima, Peru, 7School of Public Health- Universidad Peruana Cayetano Heredia, Epidemiology, STD, and HIV Unit, Lima, Peru, 8Yale School of Medicine / VA Connecticut Healthcare System, West Haven, Connecticut, New Haven, CT

    Background/Purpose: The life expectancy of people living with HIV (PLWH) has improved notably since the advent of antiretroviral therapy (ART). However, studies have shown that…
  • Abstract Number: 0167 • ACR Convergence 2024

    Epidemiology of Falls in a Diverse Cohort of Adults with SLE

    Laura Plantinga1, Charmayne M. Dunlop-Thomas2, Courtney Hoge3, Jinoos Yazdany4 and C. Barrett Bowling5, 1University of California, San Francisco, San Francisco, CA, 2Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 3Emory University, Atlanta, GA, 4UCSF, San Francisco, CA, 5Duke University, Durham, NC

    Background/Purpose: While often preventable, falls are a common, costly, and serious outcome in the U.S. population: more than one in four adults ³65 years old…
  • Abstract Number: 2224 • ACR Convergence 2024

    Age of Onset of Rheumatoid Arthritis and Radiographic Changes

    Masaru Shimizu1, Misti Paudel2, Nancy Shadick3, Michael Weinblatt4 and Daniel Solomon5, 1University of Tsukuba, Yokohama, Kanagawa, Japan, 2Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 5Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Epidemiological studies have shown that the age of onset for rheumatoid arthritis (RA) is increasing. However, associations between age of onset and joint erosion…
  • Abstract Number: 0717 • ACR Convergence 2024

    Associations Between Calendar Time and Age at Diagnosis with Mortality in a National Cohort of Veterans with ANCA-Associated Vasculitis from 2001-2020

    Jennifer Hanberg1, Svetlana Eden2, Amy Anderson-Mellies2, Suman Kundu2, Matthew Freiberg2, Zachary Wallace3 and Evelyn Hsieh4, and the Veterans Aging Cohort Study Project Team, 1Brigham and Women's Hospital, Boston, MA, 2Vanderbilt University Medical Center and Tennessee Valley VA, Nashville, TN, 3Massachusetts General Hospital, Newton, MA, 4Yale School of Medicine / VA Connecticut Healthcare System, West Haven, Connecticut, New Haven, CT

    Background/Purpose: It is not clear whether advances in ANCA-associated vasculitis (AAV) management between 2001-2020 have translated to improvement in population-level outcomes, including among older adults.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology